Vertex Pharmaceuticals Incorporated (VRTX) gained 3.49% on October 31, 2026, closing at $559.05 as the biotech firm continued a run of positive sessions. The single-day advance added to broader momentum that has built steadily over recent weeks.
Over the past seven days, shares rose 6.69%, while the 30-day gain came in at 6.93%, reflecting consistent buying pressure across both the short and medium term. The alignment of those two figures suggests the recent rally has been relatively steady rather than driven by a single sharp move.
Vertex's market capitalization stood at $136.87 billion at the close, keeping the company among the larger players in the biotechnology sector by that measure.
The stock's performance across the 24-hour, seven-day, and 30-day windows all pointed in the same direction on the session, with each timeframe showing a gain above 3%.
